Plaque Burden and Ischemia in MINOCA

Sponsor
University of Bergen (Other)
Overall Status
Recruiting
CT.gov ID
NCT05681858
Collaborator
Haukeland University Hospital (Other), Haraldsplass Deaconess Hospital (Other)
100
1
1
53
1.9

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to assess coronary artery plaque burden, perivascular inflammation and extent of myocardial ischemia in patients presenting with acute myocardial infarction and non-obstructive coronary artery disease. The main question it aims to answer are:

  • Identify coronary artery anatomy, plaque burden, composition and high-risk plaque features by CT coronary angiography in MINOCA

  • Assess presence, extent and severity of myocardial ischemia in MINOCA

Participants will examined by CT coronary angiography and stress [12N] NH3 PET-MR.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: CT coronary angiography and [12N] NH3 PET-MR
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Coronary Artery Plaque, Perivascular Inflammation and Myocardial Ischemia in Patients With Myocardial Infraction and Non-obstructive Coronary Arteries
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2027
Anticipated Study Completion Date :
Aug 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Other: CT coronary angiography and [12N] NH3 PET-MR

All patients will undergo CT coronary angiography and stress [12N] NH3 PET-MR

Diagnostic Test: CT coronary angiography and [12N] NH3 PET-MR
Advanced coronary artery plaque analysis, myocardial ischemia and coronary flow reserve

Outcome Measures

Primary Outcome Measures

  1. Plaque burden [1 week]

  2. Myocardial ischemia [1 week]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Acute chest pain

  • Elevated troponin

  • Non-obstructive coronary arteries by coronary angiography

Exclusion Criteria:
  • Obstructive coronary artery disease

  • Contraindications against CT coronary angiography or stress [12N] NH3 PET-MR

  • Not able to give informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Clinical Science, University of Bergen Bergen Norway 5021

Sponsors and Collaborators

  • University of Bergen
  • Haukeland University Hospital
  • Haraldsplass Deaconess Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mai Tone Lønnebakken, Professor M.D., University of Bergen
ClinicalTrials.gov Identifier:
NCT05681858
Other Study ID Numbers:
  • 463549
First Posted:
Jan 12, 2023
Last Update Posted:
Jan 12, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 12, 2023